Sonnet BioTherapeutics Provides Fiscal Year 2022 Business and Financial Update

Sonnet BioTherapeutics Provides Fiscal Year 2022 Business and Financial Update

PRINCETON, NJ / ACCESSWIRE / December 15, 2022 / Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) (“Sonnet” or the “Company”), a biopharmaceutical company developing innovative targeted biologic drugs, announced today its financial results for the fiscal year ended September 30th, 2022 and provided a business update. Pankaj Mohan, Ph.D., Founder and CEO commented, “This was a defining…

Read More
Money Problems? Financial Literacy Could Benefit Your Business And Employees Returning To Work

Money Problems? Financial Literacy Could Benefit Your Business And Employees Returning To Work

Financial stress can contribute to mental health issues and absenteeism pexel With prices increasing faster than wages in the past year, employers and employees both need to tighten their belts. Fortune reports that even more workers (41%) are living paycheck to paycheck than before the COVID-19 pandemic. It makes sense that Americans are increasingly stressed…

Read More
Nanobiotix Provides Business Update and Reports Financial Results for the First Half of 2022

Nanobiotix Provides Business Update and Reports Financial Results for the First Half of 2022

Pivotal Phase 3 study, NANORAY-312, actively enrolling elderly, LA-HNSCC patients ineligible for cisplatin across ~50 sites as LianBio enrolls first patient and continues to ramp up site activation in Asia and Nanobiotix adds European sites, and begins recruitment in the US Reported €63.0 million in cash and cash equivalents as of June 30, 2022 which,…

Read More